2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Rubella: new trials by email Literature Review of Rubella trials Research Report on Rubella
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP - Measles, Rubella | Phase 1 / Phase 2 | Completed | Micron Biomedical, Inc | 281 | 2021-05-19 | 2023-03-29 |
| Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Double viral (MR) vaccine - Rubella, Measles | Phase 1 | Completed | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 30 | 2015-09-01 | 2016-06-22 |
| Immune Responses to Two Dose Varivax +/- MMR-II MMR-II, Pro-Quad, Varivax - Measles, Mumps | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 105 | 2005-10-01 | 2010-08-27 |
Measles (3) · Chickenpox (1) · Mumps (1)
Infections (3) · Mononegavirales Infections (3) · Morbillivirus Infections (3) · Paramyxoviridae Infections (3) · RNA Virus Infections (3) · Rubivirus Infections (3) · Togaviridae Infections (3) · Virus Diseases (3) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Mouth Diseases (1) · Parotid Diseases (1) · Parotitis (1) · Rubulavirus Infections (1) · Salivary Gland Diseases (1)
Chickenpox Vaccine (1) · Measles Vaccine (1) · Rubella Vaccine (1) · Vaccines (1)
Micron Biomedical, Inc (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)
Brazil (1) · The Gambia (1) · United States (1)
Ed Clarke, MD (1) · Jose CerbinoNeto, PHD (1)